Genetic susceptibility to tuberculosis

Journal of Infection

Volumn 39, Issue 2, 1999, Pages 117-121

  Newport, Melanie ^a   Levin, Michael ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; GENETIC SUSCEPTIBILITY; INFECTION SENSITIVITY; NONHUMAN; REVIEW; TUBERCULOSIS;

EID: 0032724161     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90002-6     Document Type: Review

References (53)

1. Kochi A. The global tuberculosis Situation and the new control strategy of the World Health Organization. Tubercle 1991; 72: 1-6.
2. Bloom BR, Godal T. Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis 1983; 5: 765-780.
3. Benator DA, Gordin FM. Nontuberculous mycobacteria in patients with human immunodeficiency virus infection. Semin Respir Infect 1996; 11: 285-300.
4. Murray GDL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull IUATLD 1990; 65: 6-24.
5. Sorensen TIA, Nielson GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-732.
6. Fine PEM. Immunogenetics of susceptibility to leprosy, tuberculosis and leishmania. An epidemiological perspective. Int J Lepr 1981; 49: 437-454.
7. Kallman FJ, Reisner D. Twin studies on genetic variations in resistance to tuberculosis. J Hered 1943; 34: 293-301.
8. Chakravati MR, Vogel F. A twin study on leprosy. Top Hum Genet 1973; 1: 1-123.
9. Comstock G. Tuberculosis in twins: A re-analysis of the Prophit Survey. Am Rev Respir Dis 1978; 117: 621-624.
10. Plant J, Glynn AA. Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice. Nature 1974; 248: 345-347.
11. Bradley DJ. Genetic control of natural resistance to Leishmania donovani. Nature 1974; 250: 353-354.
12. Plant J, Glynn AA. Locating salmonella resistance gene on mouse Chromosome 1. Clin Exp Immunol 1979; 37: 1-6.
13. Blackwell JM. The macrophage resistance gene, Lsh/Ity/Bcg. Res Immunol 1989; 140: 767-828.
14. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 1993; 73: 469-485.
15. Blackwell JM, Searle S. Genetic regulation of macrophage activation: understanding the function of Nramp 1 (=Ity/Lsh/Bcg). Immunol Lett 1999; 65: 73-80.
16. Pfeffer K, Mak TW. Lymphocyte ontogeny and activation in gene targeted mutant mice. Annu Rev Immunol 1994; 12: 367-411.
17. Erb KJ, Kirman J, Delahunt B, Chen W, LeGros G. IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunol Cell Biol 1998; 76: 41-46.
18. Laochumroonvorapong P, Wang J, Liu CC, Ye W, Moreira AL, Elkon KB, Freedman VH, Kaplan G. Perform, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997; 65: 127-132.
19. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastians G, Malo D, Skamene E, Olivier M, Jothy S, Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J Exp Med 1995; 182: 655-666.
20. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-α is required in the protective immune response against Mycobacteruim tuberculosis in mice. Immunity 1995; 2: 561-572.
21. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-γ gene disrupted mice. J Exp Med 1993; 178: 2243-2247.
22. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-2254.
23. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178: 1435-40.
24. Flynn JL, Goldstein MM, Treibold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89: 12013-12017.
25. Ladel CH, Dauglat S, Kaufmann SHE. Immune responses to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II deficient mice: contribution of CD4 and CD8 cels to acquired resistance. Eur J Immunol 1995; 25: 377-384.
26. Ladel CH, Hess J, Daugelet S, Mombaerts P, Tonegawa S, Kaufmann SHE. Contribution of α/β and γ/δT lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor deficient mutant mice. Eur I Immunol 1995; 25: 838-846.
27. Kamijo R, Harada H, MatsuyamaT, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TM, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263: 1612-1615.
28. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SH. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997; 65: 4843-4849.
29. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin-12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186: 39-45.
30. Levin M, Newport MJ, D'Souza S, Kalabalikis P, Brown I, Lenicker H, Vassallo Agius P, Davies EG, Thrasher A, Blackwell JM. Familial disseminated atypical mycobacterial infection in early childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345: 79-83.
31. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 1995; 346: 581.
32. Casanova J-L, Blanche S, Emile J-F, Stephan J-L, Bernaudin F, Jouanguy E, Lamhamedi S, Bordigoni P, Turck D, Albertini M, Dommergues J-P, Rybojad M, Pocidalo M-A, Le Deist F, Griscelli C, Fischer A. Idiopathic disseminated bacille Calmette-Guerin infection: a French national retrospective study. Pediatrics 1996; 98: 774-778.
33. Jouanguy E, Altare F, Lamhamedi S, Revy P, Newport M, Levin M, Blanche S, Fischer A, Casanova J-L. Lethal BCG infection due to lack of interferon γ receptor: a human inherited selective susceptibility to mycobacteria. N Engl J Med 1996; 335: 1956-1959.
34. Altare F, Jouanguy E, Lamhamedi S, Doffinger R, Fischer A, Casanova J-L. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol 1998; 10: 413-417.
35. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M. A mutation in the interferon-gamma receptor gene and susceptibility to mycobacterial infections in man. N Engl J Med 1996; 335: 1941-1949.
36. Jouanguy E, Lamamedi-Cherradi S, Altare F, Fondaneche M-C, Tuerlinckx D, Blanche S, Emile J-F, Gaillard J-L, Schreiber R, Levin M, Fischer A, Hivroz C, Casanova J-L. Partial Interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerlin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100: 2658-2664.
37. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondaneche M-C, Dupuis S, Doffinger R, Altare F, Girdlestone J, Emile J-F, Ducoulombier H, Edgar D, Clarke J, Oxelius V-A, Brai M, Novelli V, Heyne K, Fischer A, Holland SM, Kumararatne D, Schreiber RD, Casanova J-L. A human IFNGRI small deletion hotspot associated with dominant susceptibility to mycobcaterial infection. Nat Genet 1999; 21: 370-378.
38. Kotenko SV, Izotova LS, Pollock BP, Mariano TM, Donnelly RJ, Muthukumaran G, Cook GR, Garotta G, Silvennoinen O, Ihle JN, Pestka S. Interaction between the components of the Interferon γ receptor complex. J Biol Chem 1995; 270: 20915-20921.
39. Altare F, Durandy A, Lammas D, Emile J-F, Lamhamedi S, Le Diest F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsonn O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumarante D. Casanova J-L. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432-1435.
40. de Jong R, Altare F, Haagen I-A, Elferink DG, de Boer T, van Breda Vriesman PJC, Kabel PJ, Draaisma JMT, van Dissel JT, Kroon FP, Casanova J-L, Ottenhoff THM. Severe mycobacterial and Salmonella infections in interleukin-12 receptor deficient patients. Science 1998; 280: 1435-1438.
41. Altare F, Lammas D, Revy P, Jouanguy E, Doffinger R, Lamhamedi S, Drysdale P, Scheel-Toellner D, Girdlestone J, Darbyshire P, Wadhwa M, Dockrell H, Salmon M, Fischer A, Durandy A, Casanova J-L, Kumararante D. Inherited interleukin 12 deficiency in a child with Bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 1998; 102: 2035-2040.
42. Ottenhoff THM, Kumararatne D, Casanova J-L. Novel human immunodeficiencies reveal teh essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 1998; 19: 491-494.
43. Bellamy R. Genetic susceptibility to tuberculosis in human populations. Thorax 1998; 53: 588-593.
44. Hauser ER, Boehnke M, Guo S-W, Risch N. Affected-sib-pair interval mapping and exclusion for complex genetic traits. Genet Epidemiol 1996; 13: 117-137.
45. Brahmajothi V, Pitchappan RM, Kakkanaiah VN, Sashidhar M, Rajaram K, Ramu S, Palanimurgan K, Paramasivan CN, Prabhakar R. Association of pulmonary tuberculosis and HLA in South India. Tubercle 1991; 72: 123-132.
46. Jepson AP, Banya WAS, Sisay-Joof F, Hassan-King M, Nunes C, Bennett S, Whittle HC. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infect. Immun 1997; 65: 872-876.
47. Bellamy R, Ruwende C, Corrah T, McAdam KPW Whittle HC, Hill AVS. Variations in the NRAMPI gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
48. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Thursz M, Whittle H, Hill AVS. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724.
49. Bellamy R, Ruwende C, Corrah T, McAdams KPWJ, Whittle HC, Hill AVS. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tubercle Lung Dis 1998; 79: 83-89.
50. Bellamy R, Ruwende C, McAdam KPWJ, Thursz M, Sumiya M, Summerfield J, Gilbert SC, Corrah T, Kwiatkowski D, Whittle HC, Hill AV. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM 1998; 91: 33-18.
51. Bellamy R, Hill AV. Host genetic susceptibility to human tuberculosis. Novartis Found Symp 1998; 217: 13-23.
52. Blackwell JM, Black GF, Peacock CS, Miller EN, Sibthorpe D, Gnananandha D, Shaw JJ, Silvera F, Lins-Lainson Z, Ramos F, Collins A, Shaw M-A. Immunogenetics of leishmanial and mycobacterial infections. Phil Trans R Soc 1997; 352: 1331-1345.
53. Shaw M-A, Collins A, Peacock CS, Miller EN, Black GF, Sibthorpe D, Lins-Lainson Z, Shaw J, Ramos F, Silveira F, Blackwell JM. Evidence that genetic susceptibility to Mycobacterium infection in a Brazilian population is under two-locus oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tubercle Lung Dis 1997; 78: 35-45.